C69.9

Clinical Causes: Genetic mutations that lead to abnormal cell growth in the eye Exposure to harmful ultraviolet (UV) light over prolonged periods History of radiation therapy to the head or eye area Chronic eye inflammation or injuries Family history of ocular or other cancers Certain genetic syndromes that increase cancer risk Environmental factors and carcinogens

Key Symptoms: Blurred or decreased vision Seeing flashes of light or floaters A visible growth or swelling in the eye Dark or irregular spots on the iris Eye pain or redness, especially if a tumor affects internal structures Change in the shape or size of the pupil Sudden loss of vision Photophobia or sensitivity to light

Diagnosis Path: Diagnosing a malignant eye tumor involves a combination of clinical examinations and imaging techniques. An ophthalmologist may perform a comprehensive eye exam to observe any abnormalities. Imaging tests such as ultrasound, MRI, or CT scans can help determine the size and location of the tumor. In some cases, a biopsy may be necessary to confirm the cancerous nature of the growth. Early diagnosis plays a vital role in successful management and treatment.

Treatment Protocols: Treatment options for malignant tumors of the eye depend on the tumor's size, location, and extent of spread, as well as the overall health of the patient. Common approaches include: - **Surgery:** Removal of the tumor or, in some cases, the entire eye (enucleation) to prevent the spread of cancer. - **Radiation therapy:** Using high-energy radiation to destroy cancer cells while preserving as much eye function as possible. - **Chemotherapy:** Administration of drugs to target malignant cells, sometimes used in conjunction with other treatments. - **Laser therapy:** Focusing intense laser beams to eliminate tumors. A multidisciplinary team of eye specialists, oncologists, and surgeons collaborates to develop a personalized treatment plan aimed at controlling the disease and maintaining vision when possible.